The Lancet Gastroenterology & Hepatology in conversation with

Edward Kim on radiation segmentectomy for unresectable very early to early stage hepatocellular carcinoma

August 04, 2022 The Lancet Gastroenterology & Hepatology
The Lancet Gastroenterology & Hepatology in conversation with
Edward Kim on radiation segmentectomy for unresectable very early to early stage hepatocellular carcinoma
Show Notes

Edward Kim (Icahn School of Medicine at Mount Sinai) discusses the single-arm RASER study of radiation segmentectomy for patients with unresectable very early to early stage hepatocellular carcinoma.

Read the full article:
Radiation segmentectomy for curative intent of unresectable very early to early stage hepatocellular carcinoma (RASER): a single-centre, single-arm study

Continue this conversation on social!
Follow us today at...
https://twitter.com/thelancet
https://instagram.com/thelancetgroup
https://facebook.com/thelancetmedicaljournal
https://linkedIn.com/company/the-lancet
https://youtube.com/thelancettv